Proteostasis Therapeutics Inc. Secures $45,000,000 Series A Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cae01090-b167-4989-9cc8-5ba24f16e7c3&Preview=1
Date
8/25/2008
Company Name
Proteostasis Therapeutics Inc.
Mailing Address
Undisclosed Cambridge, MA 02138
Company Description
Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s Proteostasis Network, which maintains the body’s natural protein homeostasis to protect us from numerous diseases. We call these new therapies “Proteostasis RegulatorsTM” and will develop them as novel therapies to treat multiple genetic and degenerative disorders associated with protein homeostasis deficiencies, such as emphysema, type II diabetes, Alzheimer’s Disease and Huntington’s Disease.
Website
http://www.proteostasis.com
Transaction Type
Venture Equity
Transaction Amount
$45,000,000
Transaction Round
Series A
Proceeds Purposes
The funding was done to develop Proteostasis Regulator(TM)Drugs.
M&A Terms
Venture Investor
HealthCare Ventures
Venture Investor
Fidelity BioSciences
Venture Investor
New Enterprise Associates
Venture Investor
Novartis BioVenture Fund
Venture Investor
Genzyme Ventures